Efficacy of compound middle-layer acid combined with 30% supramolecular salicylic acid for melasma
Objective To evaluate the therapeutic efficacy of a combination of compound middle-layer acid and 30% supramolecular salicylic acid for melasma. Methods Five female patients with melasma who were admitted to our hospital from May 2022 to December 2022 were enrolled in this study. A self-parallel con...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | zho |
Published: |
editoiral office of Journal of Diagnosis and Therapy on Dermato-venereology
2023-12-01
|
Series: | Pifu-xingbing zhenliaoxue zazhi |
Subjects: | |
Online Access: | http://pfxbzlx.gdvdc.com/EN/10.3969/j.issn.1674-8468.2023.06.004 |
_version_ | 1797249346764275712 |
---|---|
author | Yu SUN Congxiu YE Jiaojiao FU Xinling CHEN Feng ZHOU Yuhan JIANG Wei LAI Yue ZHENG |
author_facet | Yu SUN Congxiu YE Jiaojiao FU Xinling CHEN Feng ZHOU Yuhan JIANG Wei LAI Yue ZHENG |
author_sort | Yu SUN |
collection | DOAJ |
description | Objective To evaluate the therapeutic efficacy of a combination of compound middle-layer acid and 30% supramolecular salicylic acid for melasma. Methods Five female patients with melasma who were admitted to our hospital from May 2022 to December 2022 were enrolled in this study. A self-parallel controlled study was carried out. The patients' treated side was treated with compound middle-layer acid while the control side was treated with 30% supramolecular salicylic acid at weeks 0 and 4. On week 8, the treated side and control side were treated with 30% supramolecular salicylic acid and compound middle-layer acid, respectively. We compared the area score of facial lesions, skin color, sebum, water content and the severity of melasma-related psychological stress between the two sides. Results The combination therapy significantly decreased the area scores on the forehead, cheek and chin (P<0.05). In contrast, only the area scores on the forehead were decreased on the control side. Although the color scores were decreased on the forehead, cheek and chin of both sides, significant decrease was observed on the treated side (P<0.05 vs. the control side). Similarly, both treatments increased sebum content, with a prominent increase on the treated side (P<0.05 vs. the control side). The changes in water content did not differ significantly between these two treatments (P>0.10). Moreover, the combination therapy decreased both SAS (from 21.62±5.99 to 20.86±6.44, P<0.05) and SDS scores (from 25.05±4.21 to 23.33±5.12, P<0.05). Conclusions The combination therapy of compound middle-layer acid and 30% supramolecular salicylic acid can significantly improve the facial skin lesions and psychological state of patients with melasma. Better results can be achieved by using compound middle-layer acid first, followed by 30% supramolecular salicylic acid. |
first_indexed | 2024-04-24T20:29:02Z |
format | Article |
id | doaj.art-746c8e3228e7417b87f595ee054b7b34 |
institution | Directory Open Access Journal |
issn | 1674-8468 |
language | zho |
last_indexed | 2024-04-24T20:29:02Z |
publishDate | 2023-12-01 |
publisher | editoiral office of Journal of Diagnosis and Therapy on Dermato-venereology |
record_format | Article |
series | Pifu-xingbing zhenliaoxue zazhi |
spelling | doaj.art-746c8e3228e7417b87f595ee054b7b342024-03-22T02:46:48Zzhoeditoiral office of Journal of Diagnosis and Therapy on Dermato-venereologyPifu-xingbing zhenliaoxue zazhi1674-84682023-12-0130650250810.3969/j.issn.1674-8468.2023.06.004Efficacy of compound middle-layer acid combined with 30% supramolecular salicylic acid for melasmaYu SUN0Congxiu YE1Jiaojiao FU2Xinling CHEN3Feng ZHOU4Yuhan JIANG5Wei LAI6Yue ZHENG7Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, ChinaThird Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, ChinaGuangzhou Laipu Testing Technology Co. LTD., Guangzhou 510000, ChinaThird Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, ChinaThird Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, ChinaThird Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, ChinaThird Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, ChinaThird Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, ChinaObjective To evaluate the therapeutic efficacy of a combination of compound middle-layer acid and 30% supramolecular salicylic acid for melasma. Methods Five female patients with melasma who were admitted to our hospital from May 2022 to December 2022 were enrolled in this study. A self-parallel controlled study was carried out. The patients' treated side was treated with compound middle-layer acid while the control side was treated with 30% supramolecular salicylic acid at weeks 0 and 4. On week 8, the treated side and control side were treated with 30% supramolecular salicylic acid and compound middle-layer acid, respectively. We compared the area score of facial lesions, skin color, sebum, water content and the severity of melasma-related psychological stress between the two sides. Results The combination therapy significantly decreased the area scores on the forehead, cheek and chin (P<0.05). In contrast, only the area scores on the forehead were decreased on the control side. Although the color scores were decreased on the forehead, cheek and chin of both sides, significant decrease was observed on the treated side (P<0.05 vs. the control side). Similarly, both treatments increased sebum content, with a prominent increase on the treated side (P<0.05 vs. the control side). The changes in water content did not differ significantly between these two treatments (P>0.10). Moreover, the combination therapy decreased both SAS (from 21.62±5.99 to 20.86±6.44, P<0.05) and SDS scores (from 25.05±4.21 to 23.33±5.12, P<0.05). Conclusions The combination therapy of compound middle-layer acid and 30% supramolecular salicylic acid can significantly improve the facial skin lesions and psychological state of patients with melasma. Better results can be achieved by using compound middle-layer acid first, followed by 30% supramolecular salicylic acid.http://pfxbzlx.gdvdc.com/EN/10.3969/j.issn.1674-8468.2023.06.004melasmacompound middle-layer acidsalicylic acid |
spellingShingle | Yu SUN Congxiu YE Jiaojiao FU Xinling CHEN Feng ZHOU Yuhan JIANG Wei LAI Yue ZHENG Efficacy of compound middle-layer acid combined with 30% supramolecular salicylic acid for melasma Pifu-xingbing zhenliaoxue zazhi melasma compound middle-layer acid salicylic acid |
title | Efficacy of compound middle-layer acid combined with 30% supramolecular salicylic acid for melasma |
title_full | Efficacy of compound middle-layer acid combined with 30% supramolecular salicylic acid for melasma |
title_fullStr | Efficacy of compound middle-layer acid combined with 30% supramolecular salicylic acid for melasma |
title_full_unstemmed | Efficacy of compound middle-layer acid combined with 30% supramolecular salicylic acid for melasma |
title_short | Efficacy of compound middle-layer acid combined with 30% supramolecular salicylic acid for melasma |
title_sort | efficacy of compound middle layer acid combined with 30 supramolecular salicylic acid for melasma |
topic | melasma compound middle-layer acid salicylic acid |
url | http://pfxbzlx.gdvdc.com/EN/10.3969/j.issn.1674-8468.2023.06.004 |
work_keys_str_mv | AT yusun efficacyofcompoundmiddlelayeracidcombinedwith30supramolecularsalicylicacidformelasma AT congxiuye efficacyofcompoundmiddlelayeracidcombinedwith30supramolecularsalicylicacidformelasma AT jiaojiaofu efficacyofcompoundmiddlelayeracidcombinedwith30supramolecularsalicylicacidformelasma AT xinlingchen efficacyofcompoundmiddlelayeracidcombinedwith30supramolecularsalicylicacidformelasma AT fengzhou efficacyofcompoundmiddlelayeracidcombinedwith30supramolecularsalicylicacidformelasma AT yuhanjiang efficacyofcompoundmiddlelayeracidcombinedwith30supramolecularsalicylicacidformelasma AT weilai efficacyofcompoundmiddlelayeracidcombinedwith30supramolecularsalicylicacidformelasma AT yuezheng efficacyofcompoundmiddlelayeracidcombinedwith30supramolecularsalicylicacidformelasma |